Business Description
GlobeStar Therapeutics Corp
NAICS : 325412
SIC : 2836
ISIN : US37960P1049
Description
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company focused on developing therapies for serious and life-threatening rare disorders. Its lead program is a patented formulation of previously approved drugs intended for the treatment of multiple sclerosis, an approach designed to potentially accelerate development by building on existing safety and efficacy data for the underlying compounds. The company operates in the United States and is engaged primarily in research and development rather than commercial sales, meaning it does not yet generate meaningful product revenue. Its activities center on advancing its drug candidate through preclinical and clinical testing, protecting its intellectual property, and seeking regulatory clearance. Funding for operations typically comes from equity financings and similar capital-raising activities rather than from marketed products. As a small clinical-stage enterprise, its prospects depend on the success of its development programs and its ability to obtain the capital needed to continue them.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.26 | |||||
EV-to-EBITDA | -0.26 | |||||
EV-to-FCF | -1.41 | |||||
Earnings Yield (Greenblatt) % | -384.62 | |||||
FCF Yield % | -14800 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GSTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlobeStar Therapeutics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.001 | ||
| Beta | 0.8542 | ||
| 3-Year Sharpe Ratio | -0.97 | ||
| 3-Year Sortino Ratio | -1.1 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 1,241.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlobeStar Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlobeStar Therapeutics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.01:1 Stock Split | 2015-06-30 | 0.79 (+12.86%) | ||
| 0.05:1 Stock Split | 2012-08-17 | 600.00 (+11.11%) |
Show
Entries
GlobeStar Therapeutics Corp Frequently Asked Questions
What is GlobeStar Therapeutics Corp(GSTC)'s stock price today?
The current price of GSTC is $0.00. The 52 week high of GSTC is $0.00 and 52 week low is $0.00.
When is next earnings date of GlobeStar Therapeutics Corp(GSTC)?
The next earnings date of GlobeStar Therapeutics Corp(GSTC) is .
Does GlobeStar Therapeutics Corp(GSTC) pay dividends? If so, how much?
GlobeStar Therapeutics Corp(GSTC) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers